As a proven full services provider, Navitas Life Sciences brings our rich experience
from partnering with well over a 100 innovator and generic Life Sciences
companies to conduct a significant number of studies, including Phases 2
– 4, NIS, Biosimilars, and BA/BE. We have been a partner of choice for
bringing several life-saving drugs to market, and have worked across
several therapeutic areas, with significant expertise in Oncology. Our
expertise also encompasses stem cell therapies, and diagnostic imaging
and contrast agents. With a global workforce of domain experts attuned
to industry trends, we bring significant subject matter expertise,
regulatory strategy for product development, audit ready infrastructure,
a skilled and experienced delivery team, and technology platforms that
ensure compliance and are genuinely architected to enhance efficiencies
and reduce costs.
DE